FINRA Bans Firm, CEO Over Cancer Drug Kickback Scheme
The Financial Industry Regulatory Authority said Wednesday that it ousted New York-based Halcyon Cabot Partners Ltd. and two of its executives from the securities industry over allegations of widespread fraud, kickbacks...To view the full article, register now.
Already a subscriber? Click here to view full article